|
Name |
11,14-Eicosadienoic acid, methyl ester
|
Molecular Formula | C21H38O2 | |
IUPAC Name* |
methyl (11E,14E)-icosa-11,14-dienoate
|
|
SMILES |
CCCCC/C=C/C/C=C/CCCCCCCCCC(=O)OC
|
|
InChI |
InChI=1S/C21H38O2/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21(22)23-2/h7-8,10-11H,3-6,9,12-20H2,1-2H3/b8-7+,11-10+
|
|
InChIKey |
GWJCFAOQCNNFAM-ZDVGBALWSA-N
|
|
Synonyms |
2463-02-7; 11,14-Eicosadienoic acid, methyl ester; methyl (11E,14E)-icosa-11,14-dienoate; 11,14-EICOSADIENOIC ACID METHYL ESTER; Methyl eicosadienoate(all cis-11,14); cis-11,14-Eicosadienoic acid methyl ester; methyl icosa-11,14-dienoate; SCHEMBL8856554; DTXSID60881251; ZINC4544365; 11,14-Icosadienoic acid methyl ester; 11,14-Eicosadienoic acid-methyl ester; AS-63589; Methyl (11E,14E)-11,14-icosadienoate; (11E,14E)-methyl icosa-11,14-dienoate; Methyl (11E,14E)-11,14-icosadienoate #; (11Z,14Z)-11,14-Icosadienoic acid methyl ester; J-015606
|
|
CAS | 2463-02-7 | |
PubChem CID | 5365566 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 322.5 | ALogp: | 8.0 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 17 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 26.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 23 | QED Weighted: | 0.18 |
Caco-2 Permeability: | -4.875 | MDCK Permeability: | 0.00002790 |
Pgp-inhibitor: | 0.005 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.046 | 20% Bioavailability (F20%): | 0.893 |
30% Bioavailability (F30%): | 0.991 |
Blood-Brain-Barrier Penetration (BBB): | 0.096 | Plasma Protein Binding (PPB): | 100.11% |
Volume Distribution (VD): | 3.748 | Fu: | 0.78% |
CYP1A2-inhibitor: | 0.515 | CYP1A2-substrate: | 0.2 |
CYP2C19-inhibitor: | 0.47 | CYP2C19-substrate: | 0.059 |
CYP2C9-inhibitor: | 0.349 | CYP2C9-substrate: | 0.978 |
CYP2D6-inhibitor: | 0.659 | CYP2D6-substrate: | 0.323 |
CYP3A4-inhibitor: | 0.68 | CYP3A4-substrate: | 0.059 |
Clearance (CL): | 3.328 | Half-life (T1/2): | 0.691 |
hERG Blockers: | 0.316 | Human Hepatotoxicity (H-HT): | 0.195 |
Drug-inuced Liver Injury (DILI): | 0.037 | AMES Toxicity: | 0.002 |
Rat Oral Acute Toxicity: | 0.007 | Maximum Recommended Daily Dose: | 0.836 |
Skin Sensitization: | 0.969 | Carcinogencity: | 0.05 |
Eye Corrosion: | 0.913 | Eye Irritation: | 0.948 |
Respiratory Toxicity: | 0.779 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001714 | 1.000 | D0O1TC | 0.633 | ||||
ENC001605 | 0.909 | D0O1PH | 0.610 | ||||
ENC001688 | 0.853 | D0OR6A | 0.564 | ||||
ENC001435 | 0.818 | D0UE9X | 0.557 | ||||
ENC001687 | 0.800 | D07ILQ | 0.432 | ||||
ENC001583 | 0.792 | D0Z5SM | 0.395 | ||||
ENC001627 | 0.784 | D05ATI | 0.395 | ||||
ENC001845 | 0.776 | D0H2YX | 0.367 | ||||
ENC001645 | 0.773 | D00MLW | 0.364 | ||||
ENC001762 | 0.750 | D09ANG | 0.359 |